Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 712 across all filing types
Latest filing 2022-11-16 Regulatory Filings
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) confirming that the audio recording of the earnings conference call for Q2 & H1 FY23 has been uploaded on the company's website. It references Regulation 30 and 46 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which govern disclosure of material events and information. The document does not contain the transcript or detailed financial data itself, but rather announces the availability of the audio recording of the earnings call. The document length is short (1670 characters), and it serves as a notification rather than the actual earnings release or call transcript. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the availability of the earnings call recording, not the call transcript or earnings release itself.
2022-11-16 English
Newspaper Advertisements
Report Publication Announcement Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding the publication of unaudited financial results for the quarter and half year ended September 30, 2022. It references Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The document includes a copy of the newspaper advertisement for these financial results. The content is primarily an announcement of the publication of financial results rather than the full financial report itself. The document length is 15,000 characters, but the content is focused on notifying the exchanges about the newspaper advertisement and enclosing a copy of it. There is no detailed financial data or analysis presented here, only a notification and a copy of the advertisement. According to the "Menu vs Meal" rule, this is an announcement of a report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2022-11-09 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled 'Investor Presentation November 2022' and is addressed to stock exchanges (BSE and NSE) under SEBI regulations. It contains detailed company information including business overview, financial highlights, management team profiles, and strategic focus. The content is consistent with a presentation prepared for investors, focusing on company strategy, market position, and financial data highlights. There is no indication that this is a full annual or quarterly report, audit report, or earnings release. The document is not a brief announcement or a certification but a comprehensive presentation. Therefore, the document fits the category of an Investor Presentation (IP). The document length (15,000 characters) supports it being a full presentation rather than a short announcement.
2022-11-09 English
General updates
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a resolution passed by the Board of Directors of Themis Medicare Limited. The resolution mentioned is about rescinding a previous board resolution authorizing the purchase of equity shares. The document is an official announcement of a board decision and disclosure under SEBI Listing Regulations. It does not contain financial statements, audit information, or detailed financial results. It is not a report but an announcement of a board resolution and related disclosure. Therefore, it fits best under 'Capital/Financing Update' (CAP) as it relates to a financing activity (purchase of shares) being rescinded and disclosed to the market.
2022-11-09 English
Press Release
Earnings Release Classification · 95% confidence The document is a media release announcing financial results for the half year ended September 30, 2022. It contains summarized financial highlights such as revenue, EBITDA, PAT, and EPS for the quarter and half year periods. The document is relatively short (4455 characters) and is styled as a press release rather than a comprehensive financial report. It does not contain detailed financial statements or extensive analysis typical of an Interim/Quarterly Report (IR). Instead, it serves as an initial announcement of financial results, which aligns with the definition of an Earnings Release (ER). H1 2023
2022-11-08 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a notification about the rescheduling of an earnings conference call for Themis Medicare Limited. It mentions the original and new dates for the call and provides details for participation. There is no financial data or detailed financial results presented in the document. It is an announcement related to an earnings call, not the earnings release itself or a transcript. Therefore, it fits best under the category of Call Transcript (CT) if it were a transcript, but since this is only an intimation of the call schedule, it is more appropriate to classify it as a Regulatory Filing (RNS) because it is a general regulatory announcement about the scheduling of an event, not the call transcript or earnings release itself.
2022-11-08 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.